BackGwo Xi Stem Cell Applied Technology , Ltd Overview

Gwo Xi Stem Cell Applied Technology , Ltd Total Assets

Gwo Xi Stem Cell Applied Technology , Ltd's total assets is $1.1B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.12B
↑ 10.31% YoYΔ $104.44M vs prior year quarter

Peer trimmed avg / median

Loading

Gwo Xi Stem Cell Applied Technology , Ltd Total Assets History

Loading

Gwo Xi Stem Cell Applied Technology , Ltd vs. peers: Total Assets Comparison

Loading

Gwo Xi Stem Cell Applied Technology , Ltd Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Gwo Xi Stem Cell Applied Technology , Ltd (6704.TWO) FAQ

As of the most recent data (June 2026), 6704.TWO shows a total assets of $1.1B. That compares with $1B in the prior-year period — up 10.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6704.TWO's total assets is now $1.1B (was $1B) — a 10.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Gwo Xi Stem Cell Applied Technology , Ltd is outperforming or lagging.

Tracking 6704.TWO's total assets over time shows whether Gwo Xi Stem Cell Applied Technology , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1B That compares with $1B in the prior-year period — up 10.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Gwo Xi Stem Cell Applied Technology , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $1.1B) with ownership activity and broader fundamentals.

Gwo Xi Stem Cell Applied Technology , Ltd's total assets is $1.1B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.